Envoy Medical
COCH
18 hedge funds and large institutions have $3.33M invested in Envoy Medical in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
21% more capital invested
Capital invested by funds: $2.74M → $3.33M (+$587K)
0.66% less ownership
Funds ownership: 5.93% → 5.27% (-0.66%)
10% less funds holding
Funds holding: 20 → 18 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
| 2 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$105K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$19K |
| 4 |
BlackRock
New York
|
+$14.9K |
| 5 |
ACA
American Capital Advisory
Ketchum,
Idaho
|
+$5.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$388K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$189K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.42K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
COCH Hedge Fund Activity: Q3 2024 in Review
18 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2024, worth a combined $3.33M — up 21% from $2.74M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of COCH and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $190K. The largest seller was HighTower Advisors, exiting entirely with an estimated $388K sold.
- 18 institutional investors held Envoy Medical (COCH) as of Q3 2024, down from 20 in Q2 2024.
- Funds reported $3.33M of Envoy Medical stock for Q3 2024, up 21% quarter-over-quarter.
- 3 funds opened new Envoy Medical positions in Q3 2024 and 5 closed out, a net change of -2 holders.
- The largest Envoy Medical buyer in Q3 2024 was Vanguard Group, an estimated $190K added.
- The largest Envoy Medical seller in Q3 2024 was HighTower Advisors, an estimated $388K sold.
Based on aggregated 13F filings for Q3 2024.